2nd Circ. Gives New Life To DDAVP Antitrust Case
By Anne Urda ( October 19, 2009, 5:23 PM EDT) -- The U.S. Court of Appeals for the Second Circuit has overturned a lower court's dismissal of an antitrust case alleging that Ferring Pharmaceuticals Inc. and Aventis Pharmaceuticals Inc. conspired to keep generic drugs off the shelves by fraudulently acquiring a patent for diabetes drug DDAVP....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.